Freeline Therapeutics Holdings plc

What is Freeline Therapeutics Holdings plc (FRLN) stock price today?

As of Feb 16, 2024, 8:37 PM UTC, Freeline Therapeutics Holdings plc (FRLN) stock is trading at $6.49. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date FRLN stock quotes for informed trading decisions.

What is Freeline Therapeutics Holdings plc's market capitalization?

Freeline Therapeutics Holdings plc (FRLN) has a market capitalization of approximately $28.3M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Freeline Therapeutics Holdings plc's size relative to other companies in the USD market. The market cap figure updates automatically as the FRLN stock price changes.

What is the 52-week range for Freeline Therapeutics Holdings plc stock?

Freeline Therapeutics Holdings plc (FRLN) stock has traded in a 52-week range of $2.11 — $8.75. The 52-week range shows the highest and lowest prices at which FRLN traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Freeline Therapeutics Holdings plc stock price to this range provides context for recent price action.

How much trading volume does Freeline Therapeutics Holdings plc stock have?

Freeline Therapeutics Holdings plc (FRLN) stock recently traded approximately 5.3K shares. Trading volume indicates market liquidity and investor interest in FRLN. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Freeline Therapeutics Holdings plc stock.

Does Freeline Therapeutics Holdings plc pay dividends to shareholders?

Yes, Freeline Therapeutics Holdings plc (FRLN) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Freeline Therapeutics Holdings plc stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Freeline Therapeutics Holdings plc's intraday price range?

Today, Freeline Therapeutics Holdings plc (FRLN) stock has traded in a range of $6.48 — $6.49. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring FRLN's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Freeline Therapeutics Holdings plc stock data?

AlphaPilot sources real-time FRLN stock quotes, fundamental financial data, and historical price charts for Freeline Therapeutics Holdings plc from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Freeline Therapeutics Holdings plc stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of FRLN stock performance.